IONIS PHARMACEUTICALS INC IONS
- TRYNGOLZA — Familial Chylomicronemia Syndrome Approved
- TRYNGOLZA — Severe Hypertriglyceridemia Approved
- WAYLIVRA — Familial Chylomicronemia Syndrome Approved
- WAYLIVRA — Familial Partial Lipodystrophy Approved
APOC3 (1 companies · 4 programs)
Companies with an active program directed at APOC3.